Cross-sectional study of nasopharyngeal carriage of Streptococcus pneumoniae in human immunodeficiency virus-infected adults in the conjugate vaccine era

Journal of Clinical Microbiology

Volumn 46, Issue 11, 2008, Pages 3621-3625

  Onwubiko, Chinwendu ^a   Swiatlo, Edwin ^a   McDaniel, Larry S ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HEMOLYSIN; PNEUMOCOCCUS VACCINE;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL MEMBRANE; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATION; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CULTURE MEDIUM; DISEASE CARRIER; DISK DIFFUSION; EPSILOMETER TEST; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LATEX AGGLUTINATION TEST; MAJOR CLINICAL STUDY; MALE; MULTILOCUS SEQUENCE TYPING; MULTIPLEX POLYMERASE CHAIN REACTION; NASOPHARYNX; PRIORITY JOURNAL; SEROTYPE; STREPTOCOCCUS PNEUMONIAE;

ADULT; AGED; ANTI-BACTERIAL AGENTS; BACTERIAL TYPING TECHNIQUES; CARRIER STATE; CD4 LYMPHOCYTE COUNT; CROSS-SECTIONAL STUDIES; DNA FINGERPRINTING; FEMALE; GENOTYPE; HIV INFECTIONS; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; NASOPHARYNX; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SEQUENCE ANALYSIS, DNA; SEROTYPING; STREPTOCOCCUS PNEUMONIAE; VACCINES, CONJUGATE;

HUMAN IMMUNODEFICIENCY VIRUS; STREPTOCOCCUS PNEUMONIAE;

EID: 55849089919     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.01245-08     Document Type: Article

References (40)

1. Arbique, J. C., C. Poyart, P. Trieu-Cuot, G. Quesne, G. Carvalho Mda, A. G. Steigerwalt, R. E. Morey, D. Jackson, R. J. Davidson, and R. R. Facklam. 2004. Accuracy of phenotypic and genotypic testing for identification of Streptococcus pneumoniae and description of Streptococcus pseudopneumoniae sp. nov. J. Clin. Microbiol. 42:4686-4696.
2. Barry, P. M., N. Zetola, J. C. Keruly, R. D. Moore, K. A. Gebo, and G. M. Lucas. 2006. Invasive pneumococcal disease in a cohort of HIV-infected adults: incidence and risk factors, 1990-2003. AIDS 20:437-444.
3. Bogaert, D., R. De Groot, and P. W. Hermans. 2004. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect. Dis. 4:144-154.
4. Brueggemann, A. B., R. Pai, D. W. Crook, and B. Beall. 2007. Vaccine escape recombinants emerge after pneumococcal vaccination in the United States. PLoS Pathog. 3:e168.
5. Centers for Disease Control and Prevention (CDC). 2008. Invasive pneumococcal disease in children 5 years after conjugate vaccine introduction-eight states, 1998-2005. MMWR Morb. Mortal. Wkly. Rep. 57:144-148.
6. CLSI. 2008. Performance standards for antimicrobial susceptibility testing: 18th informational supplement. CLSI document M100-S18. Clinical and Laboratory Standards Institute, Wayne, PA.
7. Dworkin, M. S., J. W. Ward, D. L. Hanson, J. L. Jones, and J. E. Kaplan. 2001. Pneumococcal disease among human immunodeficiency virus-infected persons: incidence, risk factors, and impact of vaccination. Clin. Infect. Dis. 32:794-800.
8. Feikin, D. R., C. M. Elie, M. B. Goetz, J. L. Lennox, G. M. Carlone, S. Romero-Steiner, P. F. Holder, W. A. O'Brien, C. G. Whitney, J. C. Butler, and R. F. Breiman. 2001. Randomized trial of the quantitative and functional antibody responses to a 7-valent pneumococcal conjugate vaccine and/or 23-valent polysaccharide vaccine among HIV-infected adults. Vaccine 20:545-553.
9. Flannery, B., R. T. Heffernan, L. H. Harrison, S. M. Ray, A. L. Reingold, J. Hadler, W. Schaffner, R. Lynfield, A. R. Thomas, J. Li, M. Campsmith, C. G. Whitney, and A. Schuchat. 2006. Changes in invasive pneumococcal disease among HIV-infected adults living in the era of childhood pneumococcal immunization. Ann. Intern. Med. 144:1-9.
10. Grau, I., R. Pallares, F. Tubau, M. H. Schulze, F. Llopis, D. Podzamczer, J. Liñares, and F. Gudiol. 2005. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy. Arch. Intern. Med. 165:1533-1540.
11. Hammitt, L. L., D. L. Bruden, J. C. Butler, H. C. Baggett, D. A. Hurlburt, A. Reasonover, and T. W. Hennessy. 2006. Indirect effect of conjugate vaccine on adult carriage of Streptococcus pneumoniae: an explanation of trends in invasive pneumococcal disease. J. Infect. Dis. 193:1487-1494.
12. Hanage, W. P., T. Kaijalainen, E. Herva, A. Saukkoriipi, R. Syrjanen, and B. G. Spratt. 2005. Using multilocus sequence data to define the pneumococcus. J. Bacteriol. 187:6223-6230.
13. Hanage, W. P., T. Kaijalainen, A. Saukkoriipi, J. L. Rickcord, and B. G. Spratt. 2006. A successful, diverse disease-associated lineage of nontypeable pneumococci that has lost the capsular biosynthesis locus. J. Clin. Microbiol. 44:743-749.
14. Harf-Monteil, C., C. Granello, C. Le Brun, H. Monteil, and P. Riegel. 2006. Incidence and pathogenic effect of Streptococcus pseudopneumoniae. J. Clin. Microbiol. 44:2240-2241.
15. Hicks, L. A., L. H. Harrison, B. Flannery, J. L. Hadler, W. Schaffner, A. S. Craig, D. Jackson, A. Thomas, B. Beall, R. Lynfield, A. Reingold, M. M. Farley, and C. G. Whitney. 2007. Incidence of pneumococcal disease due to nonpneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J. Infect. Dis. 196:1346-1354.
16. Jacobs, M. R., C. E. Good, B. Beall, S. Bajaksouzian, A. R. Windau, and C. G. Whitney. 2008. Changes in serotypes and antimicrobial susceptibility of invasive Streptococcus pneumoniae strains in Cleveland: a quarter century of experience. J. Clin. Microbiol. 46:982-990.
17. Janoff, E. N., R. F. Breiman, C. L. Daley, and P. C. Hopewell. 1992. Pneumococcal disease during HIV infection. Epidemiologic, clinical, and immunologic perspectives. Ann. Intern. Med. 117:314-324.
18. Jordano, Q., V. Falcó, B. Almirante, A. M. Planes, O. del Valle, E. Ribera, O. Len, C. Pigrau, and A. Pahissa. 2004. Invasive pneumococcal disease in patients infected with HIV: still a threat in the era of highly active antiretroviral therapy. Clin. Infect. Dis. 38:1623-1628.
19. Keith, E. R., R. G. Podmore, T. P. Anderson, and D. R. Murdoch. 2006. Characteristics of Streptococcus pseudopneumoniae isolated from purulent sputum samples. J. Clin. Microbiol. 44:923-927.
20. Kroon, F. P., J. T. van Dissel, E. Ravensbergen, P. H. Nibbering, and R. van Furth. 2000. Enhanced antibody response to pneumococcal polysaccharide vaccine after prior immunization with conjugate pneumococcal vaccine in HIV-infected adults. Vaccine 19:886-894.
21. Kyaw, M. H., C. E. Rose, Jr., A. M. Fry, J. A. Singleton, Z. Moore, E. R. Zell, and C. G. Whitney. 2005. The influence of chronic illnesses on the incidence of invasive pneumococcal disease in adults. J. Infect. Dis. 192:377-386.
22. Metlay, J. P., N. O. Fishman, M. Joffe, and P. H. Edelstein. 2006. Impact of pediatric vaccination with pneumococcal conjugate vaccine on the risk of bacteremic pneumococcal pneumonia in adults. Vaccine 24:468-475.
23. Miiro, G., H. Kayhty, C. Watera, H. Tolmie, J. A. Whitworth, C. F. Gilks, and N. French. 2005. Conjugate pneumococcal vaccine in HIV-infected Ugandans and the effect of past receipt of polysaccharide vaccine. J. Infect. Dis. 192:1801-1805.
24. Mundy, L. S., E. N. Janoff, K. E. Schwebke, C. J. Shanholtzer, and K. E. Willard. 1998. Ambiguity in the identification of Streptococcus pneumoniae. Optochin, bile solubility, quellung, and the AccuProbe DNA probe tests. Am. J. Clin. Pathol. 109:55-61.
25. O'Brien, K. L., E. V. Millar, E. R. Zell, M. Bronsdon, R. Weatherholtz, R. Reid, J. Becenti, S. Kvamme, C. G. Whitney, and M. Santosham. 2007. Effect of pneumococcal conjugate vaccine on nasopharyngeal colonization among immunized and unimmunized children in a community-randomized trial. J. Infect. Dis. 196:1211-1220.
26. Onwubiko, C., C. Shires, L. R. Quin, E. Swiatlo, and L. S. McDaniel. 2007. Characterization of Streptococcus pneumoniae isolated from children with otitis media. FEMS Immunol. Med. Microbiol. 50:119-125.
27. Pai, R., R. E. Gertz, and B. Beall. 2006. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J. Clin. Microbiol. 44:124-131.
28. Park, I. H., D. G. Pritchard, R. Cartee, A. Brandao, M. C. Brandileone, and M. H. Nahm. 2007. Discovery of a new capsular serotype (6C) within serogroup 6 of Streptococcus pneumoniae. J. Clin. Microbiol. 45:1225-1233.
29. Pelton, S. I., H. Huot, J. A. Finkelstein, C. J. Bishop, K. K. Hsu, J. Kellenberg, S. S. Huang, R. Goldstein, and W. P. Hanage. 2007. Emergence of 19A as virulent and multidrug resistant pneumococcus in Massachusetts following universal immunization of infants with pneumococcal conjugate vaccine. Pediatr. Infect. Dis. J. 26:468-472.
30. Peñaranda, M., V. Falco, A. Payeras, Q. Jordano, A. Curran, A. Pareja, G. Samperiz, D. Dalmau, E. Ribera, and M. Riera. 2007. Effectiveness of polysaccharide pneumococcal vaccine in HIV-infected patients: a case-control study. Clin. Infect. Dis. 45:e82-e87.
31. Richter, S. S., K. P. Heilmann, C. L. Dohrn, F. Riahi, S. E. Beekmann, and G. V. Doern. 21 May 2008. Accuracy of phenotypic methods for the identification of Streptococcus pneumoniae isolates included in surveillance programs. J. Clin. Microbiol. doi:10.1128/JCM.00461-08.
32. Rodriguez-Barradas, M. C., R. A. Tharapel, J. E. Groover, K. P. Giron, C. E. Lacke, E. D. Houston, R. J. Hamill, M. C. Steinhoff, and D. M. Musher. 1997. Colonization by Streptococcus pneumoniae among human immunodeficiency virus-infected adults: prevalence of antibiotic resistance, impact of immunization, and characterization by polymerase chain reaction with BOX primers of isolates from persistent S. pneumoniae carriers. J. Infect. Dis. 175:590-597.
33. Sá-Leão, R., A. S. Simões, S. Nunes, N. G. Sousa, N. Frazão, and H. de Lencastre. 2006. Identification, prevalence and population structure of nontypeable Streptococcus pneumoniae in carriage samples isolated from preschoolers attending day-care centres. Microbiology 152:367-376.
34. Singleton, R. J., T. W. Hennessy, L. R. Bulkow, L. L. Hammitt, T. Zulz, D. A. Hurlburt, J. C. Butler, K. Rudolph, and A. Parkinson. 2007. Invasive pneumococcal disease caused by nonvaccine serotypes among Alaska native children with high levels of 7-valent pneumococcal conjugate vaccine coverage. JAMA 297:1784-1792.
35. UNAIDS. 2007. 2007 AIDS epidemic update. UNAIDS, Geneva, Switzerland.
36. Weekly Epidemiological Record. 2003. WHO recommended measures for persons undertaking international travel from areas affected by severe acute respiratory syndrome (SARS). Wkly. Epidemiol. Rec. 78:97-99.
37. Wester, C. W., D. Ariga, C. Nathan, T. W. Rice, J. Pulvirenti, R. Patel, F. Kocka, J. Ortiz, and R. A. Weinstein. 2002. Possible overestimation of penicillin resistant Streptococcus pneumoniae colonization rates due to misidentification of oropharyngeal streptococci. Diagn. Microbiol. Infect. Dis. 42:263-268.
38. Whitney, C. G., M. M. Farley, J. Hadler, L. H. Harrison, N. M. Bennett, R. Lynfield, A. Reingold, P. R. Cieslak, T. Pilishvili, D. Jackson, R. R. Facklam, J. H. Jorgensen, and A. Schuchat. 2003. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N. Engl. J. Med. 348:1737-1746.
39. Yu, J., J. Lin, W. H. Benjamin, Jr., K. B. Waites, C. H. Lee, and M. H. Nahm. 2005. Rapid multiplex assay for serotyping pneumococci with monoclonal and polyclonal antibodies. J. Clin. Microbiol. 43:156-162.
40. Yu, X., B. Gray, S. Chang, J. I. Ward, K. M. Edwards, and M. H. Nahm. 1999. Immunity to cross-reactive serotypes induced by pneumococcal conjugate vaccines in infants. J. Infect. Dis. 180:1569-1576.